Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Ostarine increases lean body mass and leg strength in postmenopausal women

July 14, 2010

Viamet describes new cytochrome P450-C17 inhibitors

July 13, 2010

Exelixis presents preclinical data on agents investigated for diabetes

July 13, 2010

Weekly rituximab reduces proteinuria in idiopathic membranous nephropathy

July 13, 2010

BHT-3021 shows promise in phase I/II trial in type 1 diabetes

July 13, 2010

Effect of citalopram on drinking depends on goals of alcohol-dependent subjects

July 13, 2010

Phase I data presented on SBI-087 in RA and SLE

July 12, 2010

Ardea describes next-generation URAT-1 inhibitor RDEA-684

July 12, 2010

Clinical trials show potential of ASP-1941 to treat type 2 diabetes

July 12, 2010

Sanwa describes preclinical pharmacology of SKL-18287 and SKL-19014

July 12, 2010

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...